Q4 Results 2024 Updates Asian Paints, BPCL, Abbott India, Alembic Pharma, SBI, HPCL announced earnings today - The Financial Express
| 4166 Stock | TWD 37.00 0.05 0.14% |
Slightly above 51% of Orient Pharma's investor base is interested to short. The analysis of current outlook of investing in Orient Pharma Co suggests that many traders are impartial regarding Orient Pharma's prospects. Orient Pharma's investing sentiment can be driven by a variety of factors including economic data, Orient Pharma's earnings reports, geopolitical events, and overall market trends.
Orient Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Orient daily returns and investor perception about the current price of Orient Pharma Co as well as its diversification or hedging effects on your existing portfolios.
Orient |
Q4 Results 2024 Updates Asian Paints, BPCL, Abbott India, Alembic Pharma, SBI, HPCL announced earnings today The Financial Express
Read at news.google.com
 |
Orient Pharma Fundamental Analysis
We analyze Orient Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orient Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orient Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Orient Pharma is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Orient Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Orient Pharma stock to make a market-neutral strategy. Peer analysis of Orient Pharma could also be used in its relative valuation, which is a method of valuing Orient Pharma by comparing valuation metrics with similar companies.
Peers
Orient Pharma Related Equities
| 8929 | Fu Burg | 2.12 | ||||
| 3607 | Coxon Precise | 0.53 | ||||
| 8342 | I Jang | 0.34 | ||||
| 1264 | Tehmag Foods | 0.32 | ||||
| 1236 | Hunya Foods | 0.66 | ||||
| 1457 | Yi Jinn | 1.03 | ||||
| 2104 | International CSRC | 3.38 | ||||
| 2062 | Sunspring Metal | 3.58 |
Additional Tools for Orient Stock Analysis
When running Orient Pharma's price analysis, check to measure Orient Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Pharma is operating at the current time. Most of Orient Pharma's value examination focuses on studying past and present price action to predict the probability of Orient Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Pharma's price. Additionally, you may evaluate how the addition of Orient Pharma to your portfolios can decrease your overall portfolio volatility.